Double-blind clinical study of cannabidiol as a secondary anticonvulsant

Authors
Category Primary study
ConferenceMarijuana '90 International Conference on Cannabis and Cannabinoids. Kolympari, Crete. International Association for Cannabinoid Medicines
Year 1990
This project was designed to evaluate the anticonvulsant activity of cannabidiol (CBD) in a group of twelve adult incompletely-controlled outpatients in a double-blind, cross-over, placebo-controlled, add-on study lasting two years. Effects of chronic CBD administration upon seizure frecuency and character, hematologic, renall and liver function, levels of existing anticonvulsant medications and upon neuropsychologic function were evaluated.
Epistemonikos ID: d41032a66cdf9e8d7244283c358128f2576a57a7